Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.27 -0.86 (-1.45%)
Streaming Delayed Price Updated: 1:33 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
News headline image
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness ↗
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country 
Via Benzinga
News headline image
Monday Markets News ↗
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved. 
Via Talk Markets
News headline image
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant ↗
 
Via Benzinga
News headline image
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs ↗
As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China. 
Via InvestorPlace
News headline image
LifeMine Therapeutics, GSK Ink $70M Drug Discovery, Development Pact ↗
 
Via Benzinga
News headline image
Drug makers, Scientists Working For Long COVID Treatments: Reuters ↗
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,  
Via Benzinga
News headline image
How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag ↗
The Food and Drug Administration on Thursday rejected a lung cancer drug Eli Lilly tested only in China, but LLY stock inched higher. 
Via Investor's Business Daily
News headline image
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC ↗
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection. 
Via Benzinga
News headline image
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market ↗
After COVID-19 vaccine-induced strength, Moderna, Inc. (NASDAQ: MRNA) is on the lookout for the next big catalyst to boost its rangebound stock. The Moderna Analyst: BofA... 
Via Benzinga
News headline image
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC ↗
U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases. 
Via Benzinga
News headline image
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC ↗
The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren& 
Via Benzinga
News headline image
News-Filled Day ↗
The price of oil fell to below $100/oz on the prospect of lower demand from the PRC. 
Via Talk Markets
News headline image
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial ↗
IDEAYA Biosciences Inc (NASDAQ: IDYA) has announced  
Via Benzinga
News headline image
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows ↗
According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE: GSK... 
Via Benzinga
News headline image
7 Drug Stocks to Consider After the Viatris Plunge ↗
As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market. 
Via InvestorPlace
News headline image
Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines ↗
Photo Credit: Photo by CDC & Klara Kulikova This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be... 
Via Benzinga
News headline image
36 Stocks To Watch After Biden's First State of The Union Address ↗
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped... 
Via Benzinga
News headline image
Putin on the brink ↗
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott. 
Via Talk Markets
News headline image
GSK Stops Additional Three Respiratory Virus Vaccine Trials In Pregnant Women ↗
GlaxoSmithKline Plc (NYSE: GSK) has halted enrollment and vaccination in three trials of its experimental vaccine against the respiratory syncytial virus (RSV) in... 
Via Benzinga
News headline image
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach ↗
Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended... 
Via Benzinga
News headline image
Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption ↗
Several former scientists and staff from companies like Johnson & Johnson (NYSE: 
Via Benzinga
News headline image
AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants ↗
The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab).... 
Via Benzinga
News headline image
Canada Approves First Plant-Based COVID-19 Vaccine ↗
As Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc's (NYSE: GSK) COVID-19 vaccine finally heads to regulators, another shot using GSK's pandemic... 
Via Benzinga
News headline image
Red Ink ↗
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph 
Via Talk Markets
News headline image
A Receding tide ↗
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient. 
Via Talk Markets
News headline image
Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data ↗
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as... 
Via Benzinga
News headline image
Holiday Over ↗
China is busily avoiding taking sides between Ukraine and Russia. 
Via Talk Markets
News headline image
Dividend Income Update January 2022 ↗
With February already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income our portfolios generated. 
Via Talk Markets
News headline image
"Prudent" Biotech Bets ↗
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look. 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.